Boyuan Wang
Lika, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Comparative effectiveness of combination therapy with nirmatrelvir-ritonavir and molnupiravir versus monotherapy with molnupiravir or nirmatrelvir-ritonavir in hospitalized COVID-19 patients: A target trial emulation study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 01, 2025
The Impact of Hypertension Onset Age on the Risk of Cardiovascular Diseases and Mortality: Two 10-Year Retrospective Cohort Studies in the United Kingdom and Hong Kong.
Journal: Journal of primary care & community health
Published: July 16, 2025
Impact of onset age of type 2 diabetes mellitus on risk of renal complications compared to age-matched non-diabetic patients: Two cohort studies in the United Kingdom and Hong Kong.
Journal: Diabetes, obesity & metabolism
Published: March 05, 2025
Optimising HbA1c monitoring intervals in patients with type 2 diabetes based on glycaemic control status: a target trial emulation study.
Journal: BJGP open
Published: January 24, 2025
Long-term effects of coronavirus disease 2019 on diabetes complications and mortality in people with diabetes: Two cohorts in the UK and Hong Kong.
Journal: Diabetes, obesity & metabolism
Published: April 12, 2023
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in Hospitalized Patients With COVID-19 : A Target Trial Emulation Study.
Journal: Annals of internal medicine
Published: March 13, 2023
Molnupiravir and nirmatrelvir-ritonavir reduce mortality risk during post-acute COVID-19 phase.
Journal: The Journal of infection
Published: February 17, 2023
Association between BNT162b2 and CoronaVac vaccination and risk of CVD and mortality after COVID-19 infection: A population-based cohort study.
Journal: Cell reports. Medicine
Published: January 07, 2023
Effectiveness of BNT162b2 and CoronaVac vaccinations against SARS-CoV-2 omicron infection in people aged 60 years or above: a case-control study.
Journal: Journal of travel medicine
Published: August 25, 2022
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.
Journal: The Journal of infection
Published: July 28, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026